Clinical Outcomes of Biodegradable Polymer-coated Ultrathin Strut Sirolimus-eluting Stents in a Real-world Patient Population: T-Flex Registry Three-year Results with High-Risk Subgroups
Prospective Evaluation of Ultrathin-strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population: Slovakia Registry with a Subgroup Analysis
Evaluation of Novel Ultrathin, Biodegradable Polymer-Coated Tetriflex Sirolimus-Eluting Stent Optimization Using Intravascular Ultrasound (IVUS) in Short Coronary Lesions (<20 mm) vs. Long Coronary Lesions (≥20 mm): Tetriflex IVUS Study
Twelve months clinical outcomes of "Nano-crush technique" for the treatment of bifurcation lesions using ultra-thin (60 μm) sirolimus-eluting coronary stents
Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups
Prospective evaluation of the Supraflex Family sirolimus-eluting coronary stent system in a ‘real-world’ patient population: Interim analysis from the S-FLEX Netherlands Registry
Ultrathin Sirolimus-eluting Stent in Real-world CAD patients: 12 months Results
Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients
Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study
Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study
Twelve months clinical outcomes after implantation of long ultra-thin strut biodegradable polymer-coated sirolimus-eluting stents in atherosclerotic coronary lesions
Performance of ultra-thin strut biodegradable polymer-coated sirolimus-eluting stent in females with coronary artery disease: results of twelve months follow-up
Clinical performance of ultra-thin strut biodegradable polymer-coated sirolimus-eluting stents in young patients with coronary artery disease: results of twelve months outcomes
Evaluation of ultra-thin strut biodegradable polymer-coated sirolimus-eluting stent in patients with small coronary arteries (≤2.5 mm)
Evaluation of clinical outcomes after ultra-thin strut (60 µm) biodegradable polymer-coated sirolimus-eluting stent implantation in patients with acute coronary syndrome
One-year clinical outcomes of ultrathin biodegradable polymer coated sirolimus eluting stents in total occlusion: a multicentre, all-comer analysis
One-year clinical outcomes of ultrathin biodegradable polymer coated sirolimus eluting stents for multivessel treatment
One-year clinical outcomes of ultra-thin strut (60 μm) biodegradable polymer-coated sirolimus-eluting coronary stents in diabetic patients
Twelve-month clinical outcomes of an ultra-thin (60 μm) strut, biodegradable polymer-coated, sirolimus-eluting coronary stent in STEMI patients – A real-world, multi-centre experience
Clinical outcomes of biodegradable polymer-coated ultrathin strut sirolimuseluting stents in a “real-world” patient population: two-year results from the T-flex registry
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TAL
Real-world use of ultrathin-strut biodegradable polymer-coated sirolimus-eluting stents in patients with coronary artery disease: 6-month clinical outcomes
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial
Slovakia Registry: Prospective evaluation of ultrathin-strut biodegradable polymer-coated sirolimus-eluting stents in an all-comers patient population
The ultra-thin strut sirolimus-eluting coronary stent: SUPRAFLEX
Twelve-month clinical outcomes of sirolimus-eluting stent in coronary artery disease: An experience in real-world Indian patients
Impact of ultra-long sirolimus-eluting stents on coronary artery lesions: one-year results of real-world FLEX-LONG Study
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimu
Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months’ results from the S-FLEX UK registry
Three-year outcomes of biodegradable polymer-coated ultra-thin (60 μm) sirolimus-eluting stents in real-world clinical practice
Clinical outcomes and complications of treatment with Supraflex stent in patients with coronary artery disease: One-year follow-up
Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry
Preliminary evaluation of clinical and angiographic outcomes with biodegradable polymer coated sirolimus-eluting stent in de novo coronary artery disease: Results of the MANIPAL-FLEX Study
Comparison of Clinical Outcomes Following Single versus Multivessel Percutaneous Coronary Intervention Using Biodegradable Polymer Coated Sirolimus-Eluting Stent in an All-comers Patient Population
Ultrathin Everolimus-eluting Stent: 3 Years Results with Subgroup of Long Lesions
Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography
Safety and clinical performance of biodegradable polymer-coated ultra-thin everolimus-eluting stents in “real-world” patients: A Multicenter Registry (PERFORM-EVER)
A “real-world” multicenter registry evaluating safety and clinical performance of biodegradable polymer-coated ultra-thin everolimus-eluting stents: 3-year results from the PERFORM-EVER registry
Safety and performance of everolimus-eluting stents comprising of biodegradable polymers with ultrathin stent platforms
New-generation ultrathin strut (60 μm) everolimus-eluting stents for coronary artery disease: an all-comer study
Twelve-month comparative analysis of clinical outcomes using biodegradable polymer-coated everolimus-eluting stents versus durable polymer-coated everolimus-eluting stents in all-comers patients
Safety and efficacy of a novel everolimus-eluting stent system in “real-world” patients with coronary artery disease: A report of preliminary outcomes
Comparison of biodegradable polymer (Everoflex) vs. permanent polymer (Xience Pro) coated everolimus-eluting coronary stent systems in all-comer patient population at a tertiary care hospital - One-year outcome study
Safety and efficacy of ultra-thin biodegradable polymer-coated everolimus-eluting stent in real-world patients with coronary artery disease – One-year outcomes of Indian multi-centric ‘EVERsafe’ study
Preliminary clinical outcomes after implantation of newer-generation biodegradable polymer-coated everolimus-eluting stent in “real-world” patients with coronary artery disease
Clinical outcomes of successful sirolimus-eluting stent implantation in patients with chronic total occlusion in the real clinical practice
Safety and efficacy of ultra-thin, biodegradable polymer coated sirolimus-eluting Supralimus-core stents in real-world patients: Outcomes at 24-month follow-up
Seven-year clinical outcomes in patients undergoing percutaneous coronary intervention with biodegradable polymer coated sirolimus-eluting stent: Results from a single-center real-world experience
Long-term clinical performance of biodegradable polymer-coated sirolimus-eluting stent in unselected real-world Saudi patients - Seven-year results from multicentre SCORES registry
Long-term clinical outcomes following ultrathin, biodegradable polymer-coated sirolimus-eluting stent implantation in diabetic vs. non-diabetic patients: results from the SCODA registry
Clinical performance of biodegradable polymer-coated sirolimus-eluting stents in unselected real-world population with coronary artery disease: results from the multicenter CORE Registry
Clinical performance of biodegradable polymer coated Sirolimus-eluting stent in multivessel disease: Results from MULTIDES study
The real world experience of the biodegradable polymer-coated sirolimus-eluting coronary stent system: Results From an "All-Comers" Clinical Experience
Evaluation of clinical outcomes in patients undergoing dual vessel percutaneous coronary intervention using sirolimus-eluting coronary stent system in India
Clinical outcomes from unselected “real-world” patients with long coronary lesion receiving 40 mm biodegradable polymer coated sirolimus-eluting stent
Nine-months clinical outcome of biodegradable polymer coated sirolimus-eluting stent system: A multi-Centre “Real-world” experience
Evaluation of prolonged safety and efficacy of biodegradable polymer coated sirolimus-eluting coronary stent system: 1-year outcomes of the INDOLIMUS Registry
Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry
Clinical performance of the cobalt-chromium biodegradable polymer coated sirolimus-eluting stent in an unselected real-world population: S-CORE Registry
Safety and Efficacy of Sirolimus-Eluting Stent in Diabetic Patients Compared with Non-Diabetic Patients Undergoing Percutaneous Coronary Intervention
Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial
Comparison of two biodegradable polymer coated, drug-eluting coronary stents paclitaxel vs. sirolimus, with 6-years clinical follow-up: BIOPRESS(BIOdegradable Polymer Registry Smt Stents) Infinnium vs. Supralimus
Early vascular healing with biodegradable polymer coated sirolimus-eluting coronary stent implantation: assessed by optical coherence tomography results at 4-month follow-up
Clinical Outcomes from Unselected Real-World Patients with Acute Myocardial Infarction Receiving Biodegradable Polymer Coated Sirolimus-Eluting Stents
Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in “real-life” percutaneous coronary intervention: 24-month data from the Manipal-S Registry
A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients
Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study
In vivo assessment of stent recoil of biodegradable polymer- coated cobalt- chromium sirolimus-eluting coronary stent system
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial
Use of Supralimus drug eluting stent with sirolimus and absorbable polymer in the treatment of acute coronary syndrome patients undergoing percutaneous coronary intervention: E- SERIES Registry
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial
Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30-month clinical follow-up results from the Series I prospective study
Analysis of 12 months clinical outcomes associated with implantation of ultrathin (60 μm) bare metal stent in an unselected real-world population with coronary artery disease
Twelve months clinical outcomes after percutaneous coronary intervention with bare metal stents in unselected real-life patients with coronary artery disease: Results from FLEXUS Study